Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice
- PMID: 17992262
- PMCID: PMC2066200
- DOI: 10.1172/JCI33372
Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice
Abstract
HDLs protect against the development of atherosclerosis, but the underlying mechanisms are poorly understood. HDL and its apolipoproteins can promote cholesterol efflux from macrophage foam cells via the ATP-binding cassette transporters ABCA1 and ABCG1. Experiments addressing the individual roles of ABCA1 and ABCG1 in the development of atherosclerosis have produced mixed results, perhaps because of compensatory upregulation in the individual KO models. To clarify the role of transporter-mediated sterol efflux in this disease process, we transplanted BM from Abca1(-/-)Abcg1(-/-) mice into LDL receptor-deficient mice and administered a high-cholesterol diet. Compared with control and single-KO BM recipients, Abca1(-/-)Abcg1(-/-) BM recipients showed accelerated atherosclerosis and extensive infiltration of the myocardium and spleen with macrophage foam cells. In experiments with isolated macrophages, combined ABCA1 and ABCG1 deficiency resulted in impaired cholesterol efflux to HDL or apoA-1, profoundly decreased apoE secretion, and increased secretion of inflammatory cytokines and chemokines. In addition, these cells showed increased apoptosis when challenged with free cholesterol or oxidized LDL loading. These results suggest that the combined effects of ABCA1 and ABCG1 in mediating macrophage sterol efflux are central to the antiatherogenic properties of HDL.
Figures







Comment in
- J Clin Invest. 117:false.
Similar articles
-
Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):279-84. doi: 10.1161/ATVBAHA.113.302781. Epub 2013 Dec 5. Arterioscler Thromb Vasc Biol. 2014. PMID: 24311381 Free PMC article.
-
Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.Circ Res. 2013 May 24;112(11):1456-65. doi: 10.1161/CIRCRESAHA.113.301086. Epub 2013 Apr 9. Circ Res. 2013. PMID: 23572498 Free PMC article.
-
Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels.Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):258-64. doi: 10.1161/ATVBAHA.107.156935. Epub 2007 Nov 15. Arterioscler Thromb Vasc Biol. 2008. PMID: 18006857
-
Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):139-43. doi: 10.1161/ATVBAHA.108.179283. Epub 2009 Oct 1. Arterioscler Thromb Vasc Biol. 2010. PMID: 19797709 Free PMC article. Review.
-
ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.Curr Drug Targets. 2011 May;12(5):647-60. doi: 10.2174/138945011795378522. Curr Drug Targets. 2011. PMID: 21039336 Review.
Cited by
-
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?Nat Med. 2012 Sep;18(9):1344-6. doi: 10.1038/nm.2937. Nat Med. 2012. PMID: 22961164 No abstract available.
-
Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children.Atherosclerosis. 2013 Jul;229(1):79-85. doi: 10.1016/j.atherosclerosis.2013.03.031. Epub 2013 Apr 19. Atherosclerosis. 2013. PMID: 23684512 Free PMC article. Clinical Trial.
-
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?Mol Neurobiol. 2016 May;53(4):2320-38. doi: 10.1007/s12035-015-9201-7. Epub 2015 May 15. Mol Neurobiol. 2016. PMID: 25976367 Review.
-
Nutritional lipidomics: molecular metabolism, analytics, and diagnostics.Mol Nutr Food Res. 2013 Aug;57(8):1319-35. doi: 10.1002/mnfr.201200808. Epub 2013 Jul 1. Mol Nutr Food Res. 2013. PMID: 23818328 Free PMC article. Review.
-
High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.J Clin Lipidol. 2020 Jan-Feb;14(1):122-132.e4. doi: 10.1016/j.jacl.2019.10.012. Epub 2019 Oct 31. J Clin Lipidol. 2020. PMID: 31791716 Free PMC article.
References
-
- Gordon D.J., Rifkind B.M. High-density lipoprotein-the clinical implications of recent studies. N. Engl. J. Med. 1989;321:1311–1316. - PubMed
-
- Glomset J.A. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 1968;9:155–167. - PubMed
-
- Kontush A., Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006;58:342–374. - PubMed
-
- Ross R. Atherosclerosis — an inflammatory disease. N. Engl. J. Med. 1999;340:115–126. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous